Clinical Trials for Dr. Falk Pharma

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Dr. Falk Pharma

Clinical Trials (5)

NCT06886360
Study with Norucholic Acid Tablets in Patients with Primary Sclerosing Cholangitis (PSC)
PHASE3Not yet recruiting
120 participants
Started: Mar 31, 2025 · Completed: Sep 30, 2027
1 condition1 sponsor0 locations
NCT05621811
Different Doses of Naronapride Vs. Placebo in Gastroparesis
PHASE2Recruiting
320 participants
Started: Jan 3, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor22 locations
NCT06596252
Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE
PHASE3Recruiting
308 participants
Started: May 21, 2021 · Completed: Jun 30, 2026
1 condition1 sponsor12 locations
NCT05083390
Norursodeoxycholic Acid vs. Placebo in NASH
PHASE2Recruiting
363 participants
Started: Jul 8, 2019 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT03872921
norUrsodeoxycholic Acid vs Placebo in PSC
PHASE3Active, not recruiting
303 participants
Started: Feb 8, 2018 · Completed: Jun 30, 2026
1 condition1 sponsor2 locations